Support Programs
For Physicians

Comprehensive Care with the Pharmacist of Their Choice

As a treating physician, you know the complexities of managing specialty medications and the rigorous follow-up they require. Accessa allows you to enroll patients in personalized support programs managed by their trusted pharmacist.

Why Choose a Program Managed by Your Patient’s Pharmacist?

The pharmacist’s accessibility and proximity to your patient ensure follow-through at every stage of treatment, allowing them to adapt to evolving needs.

Pharmacists ensure optimal care by overseeing medication therapy and conducting comprehensive evaluations of interactions. Collaborating closely with you, they monitor the patient’s health progress.

Accessa respects your patient’s right to choose their pharmacist, avoiding care fragmentation and providing a safe, supportive environment.

Enrolling your patients in Accessa’s programs prioritizes their well-being.

How Does It Work?

Accessa ensures personalized care by supporting and guiding pharmacists throughout the patient’s follow-up processes.

Each required follow-up is pre-defined and documented in the patient’s record, ensuring traceability of their treatment journey. With the patient’s consent, these records can be shared with you anytime.

Collaboration with the pharmacist reduces intermediaries, enhancing the quality of patient care and treatment continuity.

The Pharmacist: Your Ally and Your Patient’s Advocate

In Accessa’s support programs, your patient’s pharmacist serves as the primary point of contact.

  • Manages patient enrollment
  • Conducts regular follow-ups with the patient, guided by program stages
  • Documents interventions on the Curo™ platform
  • Assists patients with insurance processes and financial support requests
  • Dispenses medications and provides necessary instructions
  • Follow-up on requested tests
  • Oversees the comprehensive management of medication therapy

The Curo™ platform also collects structured clinical data on real-world medication use, enabling you to optimize therapy.

5 adalimumab (Humira™) biosimilars:

  • Hyrimoz™
  • Hulio™
  • Simlandi™
  • Amgevita™
  • Hadlima™

2 etanercept (Enbrel™) biosimilars:

  • Erelzi™
  • Brenzys™

3 pegfilgrastim (Neulasta™) biosimilars:

  • Fulphila™
  • Lapelga™
  • Ziextenzo™

2 filgrastim (Neupogen™) biosimilars:

  • Grastofil™
  • Nypozi™

2 teriflunomide (Aubagio™) generics:

  • Mantra-Teflunomide™
  • Apo Teriflunoide™

1 dimethyl fumarate (Tecfidera™) generic:

  • Apo-Dimethyl Fumarate™

Oral Iron Chelators

1 deferasirox (Janedu™, Exjade™) generic:

  • Apo-Deferasirox™

1 apremilast (Otezla™) generic:

  • Sandoz-Apremilast™

1 eltrombopag (Revolade™) generic:

  • Apo Eltrombopag™

1 fulvestrant (Faslodex™) biosimilar:

  • Fulvestrant™

1 palbociclib (Ibrance™)biosimilar

  • Taro-Palbociclib
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.